Safety & Efficacy of the Laser Scleral Microporation Procedure
Evaluation of the Safety & Efficacy of the Laser Scleral Microporation Procedure to Restore Visual Function and Range of Accommodation
Sponsor: ACE Vision Group, Inc.
Terminated
Study terminated early to pursue Gen II laser advancements
Other terminated trials from ACE Vision Group, Inc.
More terminations from ACE Vision Group, Inc.
This NA trial investigates Presbyopia and is currently terminated or withdrawn. ACE Vision Group, Inc. leads this study, which shows 6 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Nov 2023 — Jul 2024 [monthly]
Terminated NA
Status: Active Not Recruiting → Terminated
-
Sep 2022 — Nov 2023 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
May 2022 — Sep 2022 [monthly]
Recruiting NA
▶ Show 1 earlier version
-
Nov 2021 — May 2022 [monthly]
Recruiting NA
First recorded
Apr 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- ACE Vision Group, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .